Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Amato

Showing results (21-30 of 287) with videos related to

Pageof 29
Sort By:
Expert Review of Vaccines|September 5, 2008
Vaccine therapy for renal cancerRobert J Amato
Critical Care Nurse|November 1, 1982
A nursing reference: gastrointestinal tubes and drains. Part I: intra-abdominal tubes and drainsE J Amato
Clinical Genitourinary Cancer|May 30, 2006
A phase I study of paclitaxel/doxorubicin/ thalidomide in patients with androgen- independent prostate cancerRobert J Amato, Harmeet Sarao
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|March 1, 1983
Interpositional cortical plate augmentation in the reconstruction of a labially deficient alveolar processC J Amato, H Israel
Drugs|December 2, 2006
Targeted anti-cancer therapies for renal cancerRobert J Amato, Jaroslaw Jac
Oncotargets and Therapy|August 8, 2012
Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimusPutao Cen, Robert J Amato
Cancer Chemotherapy and Pharmacology|August 19, 2007
A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinomaRobert J Amato, Muhammad Khan
Investigational New Drugs|August 9, 2005
Interferon-alpha plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: a pilot studyRobert J Amato, Anish Rawat
Frontiers in Oncology|July 23, 2013
Identification of Pre- and Post-Treatment Markers, Clinical, and Laboratory Parameters Associated with Outcome in Renal Cancer Patients Treated with MVA-5T4Rabih Said, Robert J Amato
Chemical Research in Toxicology|February 13, 2014
Epimeric 2-deoxyribose lesions: Products from the improper chemical repair of 2-deoxyribose radicalsNicholas J Amato, Yinsheng Wang
Pageof 29

Showing results (21-30 of 287) with videos related to

Sort By:
Pageof 29
Expert Review of Vaccines|September 5, 2008
Vaccine therapy for renal cancerRobert J Amato
Critical Care Nurse|November 1, 1982
A nursing reference: gastrointestinal tubes and drains. Part I: intra-abdominal tubes and drainsE J Amato
Clinical Genitourinary Cancer|May 30, 2006
A phase I study of paclitaxel/doxorubicin/ thalidomide in patients with androgen- independent prostate cancerRobert J Amato, Harmeet Sarao
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|March 1, 1983
Interpositional cortical plate augmentation in the reconstruction of a labially deficient alveolar processC J Amato, H Israel
Drugs|December 2, 2006
Targeted anti-cancer therapies for renal cancerRobert J Amato, Jaroslaw Jac
Oncotargets and Therapy|August 8, 2012
Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimusPutao Cen, Robert J Amato
Cancer Chemotherapy and Pharmacology|August 19, 2007
A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinomaRobert J Amato, Muhammad Khan
Investigational New Drugs|August 9, 2005
Interferon-alpha plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: a pilot studyRobert J Amato, Anish Rawat
Frontiers in Oncology|July 23, 2013
Identification of Pre- and Post-Treatment Markers, Clinical, and Laboratory Parameters Associated with Outcome in Renal Cancer Patients Treated with MVA-5T4Rabih Said, Robert J Amato
Chemical Research in Toxicology|February 13, 2014
Epimeric 2-deoxyribose lesions: Products from the improper chemical repair of 2-deoxyribose radicalsNicholas J Amato, Yinsheng Wang
Pageof 29